Celanese Corporation CE NYSE · Basic materials · United States
$47.40 -1.68% -$0.81
Summary
42 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- Out of every 100 USD of revenue, 8.1 USD is left as free cash.
What to watch
- Repaying its net debt would take 6.4 years of operating profit.
- It cut its dividend by 96% last year.
- It earns only 3.8 USD a year on every 100 USD of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 19.9 USD for 1 USD of yearly profit. Over the last five years it was 8.2 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 11% a year over 5 years. Over the last 3 years it fell by 0.4% a year. For the next fiscal year analysts expect revenue to grow by 4.7%.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 80 USD
- Research and development 1.2 USD
- Sales and administration 11 USD
- Taxes and other 5.4 USD
- Net profit 2.7 USD
Net profit, industry median (Chemicals) 4.8 USD
Out of every 100 USD of revenue, 2.7 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 15.0 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 0.25%
- Paid out of profit
- 5.0%
You receive $0.12 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Neutral- Buy 11
- Hold 22
- Sell 4
Today's price within the analysts' price targets
The average target of $53.63 is 13% above today's price. 30% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Engineered Materials 56%
- Acetyl Chain 44%
By region
- UNITED STATES 27%
- SWITZERLAND 26%
- CHINA 19%
- GERMANY 7.9%
- SINGAPORE 7.4%
- Other 13%
Engineered Materials brings in 56% of revenue.
Segments in detail